Carnegie Investment Bank Norway is proud to have acted as Sole Bookrunner in the successful NOK 200m bond tap issue by CSAM Health AS.

The tap issue attracted strong interest from Nordic credit investors and was substantially oversubscribed. The transaction was completed at an issue price of 103.5% of the nominal amount, corresponding to an implied coupon of approximately 3m NIBOR + 390bps. Net proceeds from the tap issue will be used for general corporate purposes, including acquisitions.

CSAM is an eHealth software company headquartered in Oslo, Norway, specializing in clinical niche solutions for hospitals with presence in Norway, Sweden, Finland, Denmark and Philippines (R&D).

Carnegie congratulates Sverre Flatby and Einar Bonnevie and the rest of the CSAM team with the successful transaction and look forward to continuing our support of CSAM going forward.